Trial Profile
A Double-blind, Randomized, Comparator-controlled Study to Assess the Safety, Efficacy, and Pharmacokinetics of ACHN-490 Injection Administered IV in Patients With Complicated Urinary Tract Infections or Acute Pyelonephritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs Plazomicin (Primary) ; Levofloxacin
- Indications Pyelonephritis; Urinary tract infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Achaogen
- 22 Jan 2019 Results of pooled analysis assessing the population pharmacokinetics for Plazomicin from 7 studies :NCT00822978, NCT01034774,NCT01462136,NCT01514929,NCT01096849,NCT01970371 and NCT02486627 were published in the Antimicrobial Agents and Chemotherapy
- 29 Jan 2018 Results assessing safety and efficacy published in the Antimicrobial Agents and Chemotherapy
- 28 Apr 2015 Results assessing n vitro susceptibility profile of baseline pathogens and its relation with study outcomes presented at the 25th European Congress of Clinical Microbiology and Infectious Diseases .